726 related articles for article (PubMed ID: 29212389)
21. Emergence of Macrolide-Resistant Mycoplasma pneumoniae in Hong Kong Is Linked to Increasing Macrolide Resistance in Multilocus Variable-Number Tandem-Repeat Analysis Type 4-5-7-2.
Ho PL; Law PY; Chan BW; Wong CW; To KK; Chiu SS; Cheng VC; Yam WC
J Clin Microbiol; 2015 Nov; 53(11):3560-4. PubMed ID: 26338857
[TBL] [Abstract][Full Text] [Related]
22. A study of community-acquired
Yu HX; Zhao MM; Pu ZH; Ju YR; Liu Y
Colomb Med (Cali); 2018 Jun; 49(2):160-163. PubMed ID: 30104808
[TBL] [Abstract][Full Text] [Related]
23. Adult community-acquired pneumonia caused by macrolide resistant Mycoplasma pneumoniae.
Isozumi R; Yoshimine H; Morozumi M; Ubukata K; Ariyoshi K
Respirology; 2009 Nov; 14(8):1206-8. PubMed ID: 19732389
[TBL] [Abstract][Full Text] [Related]
24. Community outbreak of macrolide-resistant Mycoplasma pneumoniae in Yamagata, Japan in 2009.
Suzuki Y; Itagaki T; Seto J; Kaneko A; Abiko C; Mizuta K; Matsuzaki Y
Pediatr Infect Dis J; 2013 Mar; 32(3):237-40. PubMed ID: 23114374
[TBL] [Abstract][Full Text] [Related]
25. Macrolide-Resistant Mycoplasma pneumoniae Infections in Pediatric Community-Acquired Pneumonia.
Chen YC; Hsu WY; Chang TH
Emerg Infect Dis; 2020 Jul; 26(7):1382-1391. PubMed ID: 32568052
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of tetracyclines and fluoroquinolones for the treatment of macrolide-refractory Mycoplasma pneumoniae pneumonia in children: a systematic review and meta-analysis.
Ahn JG; Cho HK; Li D; Choi M; Lee J; Eun BW; Jo DS; Park SE; Choi EH; Yang HJ; Kim KH
BMC Infect Dis; 2021 Sep; 21(1):1003. PubMed ID: 34563128
[TBL] [Abstract][Full Text] [Related]
27. Survey of macrolide-resistant Mycoplasma pneumoniae in children with community-acquired pneumonia in Switzerland.
Meyer Sauteur PM; Bleisch B; Voit A; Maurer FP; Relly C; Berger C; Nadal D; Bloemberg GV
Swiss Med Wkly; 2014; 144():w14041. PubMed ID: 25254315
[No Abstract] [Full Text] [Related]
28. First detection and characterization of macrolide-resistant Mycoplasma pneumoniae strains in Cuba.
Rodriguez N; Mondeja B; Sardiñas R; Vega D; Dumke R
Int J Infect Dis; 2019 Mar; 80():115-117. PubMed ID: 30634044
[TBL] [Abstract][Full Text] [Related]
29. Community-acquired pneumonia caused by macrolide-resistant Mycoplasma pneumoniae in adults.
Hanada S; Morozumi M; Takahashi Y; Mochizuki S; Sato T; Suzuki S; Uruga H; Takaya H; Miyamoto A; Morokawa N; Ubukata K; Kishi K
Intern Med; 2014; 53(15):1675-8. PubMed ID: 25088885
[TBL] [Abstract][Full Text] [Related]
30. Life-threatening pneumonia caused by macrolide-resistant Mycoplasma pneumoniae.
Hsieh YC; Tsao KC; Huang CG; Tong S; Winchell JM; Huang YC; Shia SH; Lai SH; Lin TY
Pediatr Infect Dis J; 2012 Feb; 31(2):208-9. PubMed ID: 21941216
[TBL] [Abstract][Full Text] [Related]
31. Emerging macrolide resistance in Mycoplasma pneumoniae in children: detection and characterization of resistant isolates.
Li X; Atkinson TP; Hagood J; Makris C; Duffy LB; Waites KB
Pediatr Infect Dis J; 2009 Aug; 28(8):693-6. PubMed ID: 19633515
[TBL] [Abstract][Full Text] [Related]
32. Macrolide-Resistant Mycoplasma pneumoniae Infection, Japan, 2008-2015.
Tanaka T; Oishi T; Miyata I; Wakabayashi S; Kono M; Ono S; Kato A; Fukuda Y; Saito A; Kondo E; Teranishi H; Tanaka Y; Wakabayashi T; Akaike H; Ogita S; Ohno N; Nakano T; Terada K; Ouchi K
Emerg Infect Dis; 2017 Oct; 23(10):1703-1706. PubMed ID: 28930026
[TBL] [Abstract][Full Text] [Related]
33. Differences in the frequency of 23S rRNA gene mutations in Mycoplasma pneumoniae between children and adults with community-acquired pneumonia: clinical impact of mutations conferring macrolide resistance.
Yoo SJ; Kim HB; Choi SH; Lee SO; Kim SH; Hong SB; Sung H; Kim MN
Antimicrob Agents Chemother; 2012 Dec; 56(12):6393-6. PubMed ID: 23006753
[TBL] [Abstract][Full Text] [Related]
34. [The epidemiological characteristics and drug resistance of mycoplasma pneumoniae in patients with community-acquired pneumonia during 2011-2015 in 5 sentinel hospitals in Beijing].
Shi WX; Wu SS; Gong C; Li AH; Huang F
Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Sep; 51(9):832-836. PubMed ID: 28881550
[No Abstract] [Full Text] [Related]
35. Clinical Characteristics of Macrolide-Resistant Mycoplasma pneumoniae from Children in Jeju.
Kim YJ; Shin KS; Lee KH; Kim YR; Choi JH
J Korean Med Sci; 2017 Oct; 32(10):1642-1646. PubMed ID: 28875608
[TBL] [Abstract][Full Text] [Related]
36. Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children.
Okada T; Morozumi M; Tajima T; Hasegawa M; Sakata H; Ohnari S; Chiba N; Iwata S; Ubukata K
Clin Infect Dis; 2012 Dec; 55(12):1642-9. PubMed ID: 22972867
[TBL] [Abstract][Full Text] [Related]
37. Phase-shifting of the transmissibility of macrolide-sensitive and resistant Mycoplasma pneumoniae epidemics in Hong Kong, from 2015 to 2018.
Zhao S; Musa SS; Qin J; He D
Int J Infect Dis; 2019 Apr; 81():251-253. PubMed ID: 30822543
[TBL] [Abstract][Full Text] [Related]
38. Emergence of macrolide-resistant strains during an outbreak of Mycoplasma pneumoniae infections in children.
Chironna M; Sallustio A; Esposito S; Perulli M; Chinellato I; Di Bari C; Quarto M; Cardinale F
J Antimicrob Chemother; 2011 Apr; 66(4):734-7. PubMed ID: 21393214
[TBL] [Abstract][Full Text] [Related]
39. Antimicrobial and immunomodulatory effect of clarithromycin on macrolide-resistant Mycoplasma pneumoniae.
Kurata S; Taguchi H; Sasaki T; Fujioka Y; Kamiya S
J Med Microbiol; 2010 Jun; 59(Pt 6):693-701. PubMed ID: 20223900
[TBL] [Abstract][Full Text] [Related]
40. [Servere atypical pneumonia with macrolide-resistant Mycoplasma pneumoniae].
Bruno Pedersen AS; Østergaard L; Jespersen S
Ugeskr Laeger; 2018 Jul; 180(30):. PubMed ID: 30037385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
